Credit Suisse Ag Glaukos Corp Call Options Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GKOS
# of Institutions
354Shares Held
50MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$951 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$707 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.16MShares$256 Million0.06% of portfolio
-
State Street Corp Boston, MA2.06MShares$244 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$228 Million0.08% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $5.63B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...